Web NewDrugInformation.com

Dianeal Pd-1 W/ Dextrose 2.5% In Plastic Container Drug - Dianeal Pd-1 W/ Dextrose 2.5% In Plastic Container The trade name of the product as shown on the labeling. Dosage - SOLUTION; INTRAPERITONEAL The product dosage form and route separated by a semi-colon. Active Ingredient(s) - Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Multiple ingredients are in alphabetical order. Strength - 25.7MG/100ML;2.5GM/100ML;15.2MG/100ML;567MG/100ML;392MG/100ML The potency of the active ingredient(s), Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate. May repeat for multiple part products. Applicant - BAXTER HLTHCARE The firm name holding legal responsibility for Dianeal Pd-1 W/ Dextrose 2.5% In Plastic Container. The firm name is condensed to a maximum twenty character unique string. New Drug Application (NDA) Number - 017512 The FDA assigned number to Dianeal Pd-1 W/ Dextrose 2.5% In Plastic Container. Format is nnnnnn. Product Number - 008 The FDA assigned number to identify Dianeal Pd-1 W/ Dextrose 2.5% In Plastic Container. Each strength is a separate product. May repeat for multiple part products. Format is nnn. Therapeutic Equivalence (TE) Code - AT The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products. Approval Date - Jul 9, 1984 The date Dianeal Pd-1 W/ Dextrose 2.5% In Plastic Container was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982". Reference Listed Drug (RLD) - No The pioneer or innovator of Dianeal Pd-1 W/ Dextrose 2.5% In Plastic Container. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No. Type - RX The group or category of approved drugs Dianeal Pd-1 W/ Dextrose 2.5% In Plastic Container is in. Format is RX, OTC, DISCN. Applicant Full Name - Baxter Healthcare Corp The full name of the firm holding legal responsibility for the new application of Dianeal Pd-1 W/ Dextrose 2.5% In Plastic Container. Dianeal Pd-1 W/ Dextrose 2.5% In Plastic Container Dianeal Pd-1 W/ Dextrose 1.5% In Plastic Container 25.7mg/100ml;1.5gm/100ml;15.2mg/100ml;567mg/100ml;392mg/100ml Solution; Intraperitoneal Dianeal Pd-1 W/ Dextrose 2.5% In Plastic Container 25.7mg/100ml;2.5gm/100ml;15.2mg/100ml;567mg/100ml;392mg/100ml Solution; Intraperitoneal Dialyte Lm/ Dextrose 4.25% In Plastic Container 26mg/100ml;4.25gm/100ml;5mg/100ml;530mg/100ml;450mg/100ml Solution; Intraperitoneal Dianeal 137 W/ Dextrose 1.5% In Plastic Container 25.7mg/100ml;1.5gm/100ml;15.2mg/100ml;567mg/100ml;392mg/100ml Solution; Intraperitoneal Dianeal 137 W/ Dextrose 2.5% In Plastic Container 25.7mg/100ml;2.5gm/100ml;15.2mg/100ml;567mg/100ml;392mg/100ml Solution; Intraperitoneal Dianeal 137 W/ Dextrose 4.25% In Plastic Container 25.7mg/100ml;4.25gm/100ml;15.2mg/100ml;567mg/100ml;392mg/100ml Solution; Intraperitoneal Dianeal Low Calcium W/ Dextrose 1.5% In Plastic Container 18.3mg/100ml;1.5gm/100ml;5.08mg/100ml;538mg/100ml;448mg/100ml Solution; Intraperitoneal Dianeal Low Calcium W/ Dextrose 2.5% In Plastic Container 18.3mg/100ml;2.5gm/100ml;5.08mg/100ml;538mg/100ml;448mg/100ml Solution; Intraperitoneal Dianeal Low Calcium W/ Dextrose 3.5% In Plastic Container 18.3mg/100ml;3.5gm/100ml;5.08mg/100ml;538mg/100ml;448mg/100ml Solution; Intraperitoneal Dianeal Low Calcium W/ Dextrose 4.25% In Plastic Container 18.3mg/100ml;4.25gm/100ml;5.08mg/100ml;538mg/100ml;448mg/100ml Solution; Intraperitoneal NewDrugInformation